Skip to main content
Amy Yau, MD, Nephrology, Columbus, OH

Amy Yau MD FACP FASN AHSCP-CHS

Acute Renal Failure, Hereditary Kidney Disease Genetics, Hypertension


Physician

Join to View Full Profile
  • 543 Taylor AveColumbus, OH 43203

  • Phone+1 614-293-4837

  • Fax+1 614-293-3125

Dr. Yau is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Nephrology, 2018 - 2020
  • William Beaumont Army Medical Center
    William Beaumont Army Medical CenterResidency, Internal Medicine, 2011 - 2014
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 2011
  • Ohio University
    Ohio UniversityB.S., Biological Sciences, and Biochemistry/Chemistry, 2004 - 2007

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2013 - 2025
  • AZ State Medical License
    AZ State Medical License 2019 - 2023
  • TX State Medical License
    TX State Medical License 2018 - 2020
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Nephrology
    American Board of Internal Medicine Nephrology

Publications & Presentations

PubMed

Press Mentions

  • SGLT2 Inhibitors Might Lower Stone Risk Better Than Other Type 2 Diabetes Drugs
    SGLT2 Inhibitors Might Lower Stone Risk Better Than Other Type 2 Diabetes DrugsMarch 12th, 2025
  • Wexner Medical Center Gives First Renal Denervation Ultrasound Procedure for High Blood Pressure in Central Ohio
    Wexner Medical Center Gives First Renal Denervation Ultrasound Procedure for High Blood Pressure in Central OhioNovember 26th, 2024
  • SGLT2 Inhibitors Might Lower Stone Risk Better Than Other Type 2 Diabetes Drugs
    SGLT2 Inhibitors Might Lower Stone Risk Better Than Other Type 2 Diabetes DrugsNovember 15th, 2024
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: